Transmedics
TMDX
110 hedge funds and large institutions have $561M invested in Transmedics in 2022 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 38 increasing their positions, 34 reducing their positions, and 27 closing their positions.
46% more capital invested
Capital invested by funds: $385M → $561M (+$177M)
43% more call options, than puts
Call options by funds: $824K | Put options by funds: $576K
12% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 34
2.27% more ownership
Funds ownership: 72.31% → 74.59% (+2.3%)
9% less funds holding
Funds holding: 121 → 110 (-11)
37% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 27
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$7.62M |
| 2 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
+$6.81M |
| 3 |
Fidelity International
Hamilton,
Bermuda
|
+$5M |
| 4 |
KLC
Kent Lake Capital
Reno,
Nevada
|
+$3.58M |
| 5 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
+$3.26M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$3.19M |
| 2 |
State Street
Boston,
Massachusetts
|
-$2.67M |
| 3 |
HP
Harbourvest Partners
Boston,
Massachusetts
|
-$2.23M |
| 4 |
Luther King Capital Management (LKCM)
Fort Worth,
Texas
|
-$1.37M |
| 5 |
Two Sigma Investments
New York
|
-$1.03M |
TMDX Hedge Fund Activity: Q1 2022 in Review
110 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Transmedics (TMDX) for Q1 2022, worth a combined $561M — up 46% from $385M a quarter earlier.
Sellers outnumbered buyers: 27 funds closed out of TMDX and 17 opened new positions — a net loss of 10 holders — while 34 trimmed existing stakes and 38 added.
The largest buyer was Macquarie Group, adding an estimated $7.62M. The largest seller was T. Rowe Price Associates, cutting an estimated $3.19M.
- 110 institutional investors held Transmedics (TMDX) as of Q1 2022, down from 121 in Q4 2021.
- Funds reported $561M of Transmedics stock for Q1 2022, up 46% quarter-over-quarter.
- 17 funds opened new Transmedics positions in Q1 2022 and 27 closed out, a net change of -10 holders.
- The largest Transmedics buyer in Q1 2022 was Macquarie Group, an estimated $7.62M added.
- The largest Transmedics seller in Q1 2022 was T. Rowe Price Associates, an estimated $3.19M sold.
Based on aggregated 13F filings for Q1 2022.